VALIANTLAB stock news
This page provides real-time market news, earnings updates, and company announcements related to Valiant Laboratories Ltd. (VALIANTLAB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-16 05:49 IST
Capital One acquires Brex for steep discount to its peak valuation, but early believers are laughing all the way to the bank
101 finance2026-01-22 23:57:12
Upstream Bio's Selloff May Be 'Overdone,' But Analyst Highlights Asthma Drug's Competitive Edge Concerns
Finviz2026-02-13 15:48:11
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Finviz2026-03-01 14:48:40
VALIANTLAB stock price change
On the last trading day, VALIANTLAB stock closed at 51.79 INR, with a price change of -4.23% for the day.
Trade stock perpsVALIANTLAB stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more